Abstract
Sexual dysfunction is a frequent side effect of selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors. However, accompanying the alteration in testosterone levels is uncommon. We present the case of a patient with major depressive disorder, posttraumatic stress disorder, and panic disorder, whose symptoms were well-controlled with venlafaxine-extended release (150 mg/d). Because of low testosterone levels, the venlafaxine treatment was tapered off.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical Science and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
